Study: HDL cholesterol, heart risk aren't linked in statin users

07/22/2010 | HealthDay News

A U.S. study suggests that patients with a low level of LDL, or "bad," cholesterol as a result of using a high-dose statin, such as AstraZeneca's Crestor, might not benefit from a high level of HDL, or "good," cholesterol. The finding suggests that "once on a high-dose statin, it is unclear if HDL cholesterol remains an important determinant of residual risk" of cardiovascular disease, the lead author said.

View Full Article in:

HealthDay News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
CareFusion
Minneapolis, MN
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Senior Paralegal - Research & Development, and Medical
Boehringer Ingelheim
CT
Junior to Mid-Level FDA Associate
Morgan Lewis
Washington, DC
Senior Counsel – Regulatory Affairs
RAI Services Company
Winston-Salem, NC